Vergoeding 2015-2019 voor ATC-subgroep C08CA : Dihydropyridinederivaten
- Raming voor de totale Zvw-populatie
| 2015 | 2016 | 2017 | 2018 | 2019 | |
|---|---|---|---|---|---|
| C08CA01 Amlodipine (Norvasc ®) | 2.927.200 | 3.117.100 | 3.619.700 | 3.555.900 | 5.095.500 |
| C08CA02 Felodipine (Plendil ®) | 672.880 | 640.970 | 588.990 | 569.890 | 576.110 |
| C08CA03 Isradipine | 285.120 | 227.850 | 204.240 | 48.923 | 488 |
| C08CA04 Nicardipine | 69.957 | 42.854 | 53 | . | . |
| C08CA05 Nifedipine (Adalat ®) | 7.368.000 | 7.085.900 | 6.768.400 | 6.576.900 | 7.196.000 |
| C08CA06 Nimodipine (Nimotop ®) | 16.539 | 15.542 | 11.532 | 16.337 | 12.967 |
| C08CA08 Nitrendipine (Baypress ®) | 70.793 | 67.526 | 57.588 | 24.734 | . |
| C08CA09 Lacidipine | 98.777 | 95.462 | 85.891 | 84.288 | 75.421 |
| C08CA12 Barnidipine (Cyress ®) | 14.377.600 | 15.717.300 | 16.927.500 | 17.857.300 | 18.013.900 |
| C08CA13 Lercanidipine (Lerdip ®) | 800.850 | 821.690 | 904.910 | 959.320 | 1.101.100 |
| Totaal | 26.687.716 | 27.832.194 | 29.168.804 | 29.693.592 | 32.071.486 |